Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Universitätsklinik für Innere Medizin

Klinische Abteilung für Onkologie

SCI/PUBMED gelistet | alle Publikationstypen | Gesamt nach Jahr und Erstautor | MUG-Autor*innen |

** = Publikationen gelistet in SCI/SSCI/Pubmed

Beiträge in Fachzeitschriften

** Al-Zoughbi, W; Pichler, M; Gorkiewicz, G; Guertl-Lackner, B; Haybaeck, J; Jahn, SW; Lackner, C; Liegl-Atzwanger, B; Popper, H; Schauer, S; Nusshold, E; Kindt, AS; Trajanoski, Z; Speicher, MR; Haemmerle, G; Zimmermann, R; Zechner, R; Vesely, PW; Hoefler, G Loss of adipose triglyceride lipase is associated with human cancer and induces mouse pulmonary neoplasia.
Oncotarget. 2016; 7(23):33832-33840 Doi: 10.18632/oncotarget.9418 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Belaj, K; Pichler, M; Hackl, G; Rief, P; Eller, P; Hafner, F; Brodmann, M; Gary, T Association of the Derived Neutrophil-Lymphocyte Ratio With Critical Limb Ischemia.
Angiology. 2016; 67(4):350-354 Doi: 10.1177/0003319715590701
Web of Science PubMed FullText FullText_MUG

 

** Belic, J; Koch, M; Ulz, P; Auer, M; Gerhalter, T; Mohan, S; Fischereder, K; Petru, E; Bauernhofer, T; Geigl, JB; Speicher, MR; Heitzer, E mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNA.
Adv Exp Med Biol. 2016; 924:147-155 Doi: 10.1007/978-3-319-42044-8_28
Web of Science PubMed FullText FullText_MUG

 

** Bonin, S; Donada, M; Bussolati, G; Nardon, E; Annaratone, L; Pichler, M; Chiaravalli, AM; Capella, C; Hoefler, G; Stanta, G A synonymous EGFR polymorphism predicting responsiveness to anti-EGFR therapy in metastatic colorectal cancer patients.
Tumour Biol. 2016; 37(6):7295-7303 Doi: 10.1007/s13277-015-4543-3
Web of Science PubMed FullText FullText_MUG

 

** Cerk, S; Schwarzenbacher, D; Adiprasito, JB; Stotz, M; Hutterer, GC; Gerger, A; Ling, H; Calin, GA; Pichler, M Current Status of Long Non-Coding RNAs in Human Breast Cancer.
Int J Mol Sci. 2016; 17(9): Doi: 10.3390/ijms17091485 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Goldzweig, G; Baider, L; Andritsch, E; Rottenberg, Y Hope and social support in elderly patients with cancer and their partners: an actor-partner interdependence model.
Future Oncol. 2016; 12(24):2801-2809 Doi: 10.2217/fon-2016-0267
Web of Science PubMed FullText FullText_MUG

 

** Hatzl, S; Geiger, O; Kuepper, MK; Caraffini, V; Seime, T; Furlan, T; Nussbaumer, E; Wieser, R; Pichler, M; Scheideler, M; Nowek, K; Jongen-Lavrencic, M; Quehenberger, F; Wölfler, A; Troppmair, J; Sill, H; Zebisch, A Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIP.
Cancer Res. 2016; 76(12):3644-3654 Doi: 10.1158/0008-5472.CAN-15-3049 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Kainhofer, V; Smolle, MA; Szkandera, J; Liegl-Atzwanger, B; Maurer-Ertl, W; Gerger, A; Riedl, J; Leithner, A The width of resection margins influences local recurrence in soft tissue sarcoma patients.
Eur J Surg Oncol. 2016; 42(6):899-906 Doi: 10.1016/j.ejso.2016.03.026
Web of Science PubMed FullText FullText_MUG

 

** Kammerer, S; Jahn, SW; Winter, E; Eidenhammer, S; Rezania, S; Regitnig, P; Pichler, M; Schreibmayer, W; Bauernhofer, T Critical evaluation of KCNJ3 gene product detection in human breast cancer: mRNA in situ hybridisation is superior to immunohistochemistry.
J Clin Pathol. 2016; 69(12):1116-1121 Doi: 10.1136/jclinpath-2016-203798 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Kammerer, S; Sokolowski, A; Hackl, H; Platzer, D; Jahn, SW; El-Heliebi, A; Schwarzenbacher, D; Stiegelbauer, V; Pichler, M; Rezania, S; Fiegl, H; Peintinger, F; Regitnig, P; Hoefler, G; Schreibmayer, W; Bauernhofer, T KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients.
Oncotarget. 2016; 7(51):84705-84717 Doi: 10.18632/oncotarget.13224 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Kanlikilicer, P; Rashed, MH; Bayraktar, R; Mitra, R; Ivan, C; Aslan, B; Zhang, X; Filant, J; Silva, AM; Rodriguez-Aguayo, C; Bayraktar, E; Pichler, M; Ozpolat, B; Calin, GA; Sood, AK; Lopez-Berestein, G Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells.
Cancer Res. 2016; 76(24):7194-7207 Doi: 10.1158/0008-5472.CAN-16-0714 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients.
Tumour Biol. 2016; 37(1):361-368 Doi: 10.1007/s13277-015-3805-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Ling, H; Krassnig, L; Bullock, MD; Pichler, M MicroRNAs in Testicular Cancer Diagnosis and Prognosis.
Urol Clin North Am. 2016; 43(1):127-134 Doi: 10.1016/j.ucl.2015.08.013
Web of Science PubMed FullText FullText_MUG

 

** Ling, H; Pickard, K; Ivan, C; Isella, C; Ikuo, M; Mitter, R; Spizzo, R; Bullock, M; Braicu, C; Pileczki, V; Vincent, K; Pichler, M; Stiegelbauer, V; Hoefler, G; Almeida, MI; Hsiao, A; Zhang, X; Primrose, J; Packham, G; Liu, K; Bojja, K; Gafà, R; Xiao, L; Rossi, S; Song, JH; Vannini, I; Fanini, F; Kopetz, S; Zweidler-McKay, P; Wang, X; Ionescu, C; Irimie, A; Fabbri, M; Lanza, G; Hamilton, SR; Berindan-Neagoe, I; Medico, E; Mirnezami, A; Calin, GA; Nicoloso, MS The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis.
Gut. 2016; 65(6):977-989 Doi: 10.1136/gutjnl-2015-309372 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Lipp, RW; Kump, PK Recent therapy options of gastrointestinal neuroendocrine tumours
AUST J CLIN ENDOCR M. 2016; 9(1): 7-10. [OPEN ACCESS]
Web of Science

 

** Mayr, C; Beyreis, M; Wagner, A; Pichler, M; Neureiter, D; Kiesslich, T Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers.
Biomed Res Int. 2016; 2016(12):4805270-4805270 Doi: 10.1155/2016/4805270 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Mayr, C; Wagner, A; Loeffelberger, M; Bruckner, D; Jakab, M; Berr, F; Di Fazio, P; Ocker, M; Neureiter, D; Pichler, M; Kiesslich, T The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells.
Oncotarget. 2016; 7(1):745-758 Doi: 10.18632/oncotarget.6378 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Meggiolaro, E; Berardi, MA; Andritsch, E; Nanni, MG; Sirgo, A; Samorì, E; Farkas, C; Ruffilli, F; Caruso, R; Bellé, M; Juan Linares, E; de Padova, S; Grassi, L Cancer patients' emotional distress, coping styles and perception of doctor-patient interaction in European cancer settings.
Palliat Support Care. 2016; 14(3):204-211 Doi: 10.1017/S1478951515000760
Web of Science PubMed FullText FullText_MUG

 

** Ohtsuka, M; Ling, H; Ivan, C; Pichler, M; Matsushita, D; Goblirsch, M; Stiegelbauer, V; Shigeyasu, K; Zhang, X; Chen, M; Vidhu, F; Bartholomeusz, GA; Toiyama, Y; Kusunoki, M; Doki, Y; Mori, M; Song, S; Gunther, JR; Krishnan, S; Slaby, O; Goel, A; Ajani, JA; Radovich, M; Calin, GA H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal Cancer.
EBioMedicine. 2016; 13(3):113-124 Doi: 10.1016/j.ebiom.2016.10.026 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Pehserl, AM; Ress, AL; Stanzer, S; Resel, M; Karbiener, M; Stadelmeyer, E; Stiegelbauer, V; Gerger, A; Mayr, C; Scheideler, M; Hutterer, GC; Bauernhofer, T; Kiesslich, T; Pichler, M Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells.
Int J Mol Sci. 2016; 17(12): Doi: 10.3390/ijms17122011 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Perakis, SO; Thomas, JE; Pichler, M Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.
Adv Exp Med Biol. 2016; 937(4):183-204 Doi: 10.1007/978-3-319-42059-2_10
Web of Science PubMed FullText FullText_MUG

 

** Popper, HH; Gruber-Mosenbacher, U; Hutarew, G; Hochmair, M; Absenger, G; Brcic, L; Mullauer, L; Dekan, G; Setinek, U; Krenbek, D; Vesely, M; Pirker, R; Hilbe, W; Kolb, R; Webersinke, G; Hernler, T; Pall, G; Lax, S; Mohn-Staudner, A Recommendations of the Austrian Working Group on Pulmonary Pathology and Oncology for predictive molecular and immunohistochemical testing in non-small cell lung cancer
MEMO-MAG EUR MED ONC. 2016; 9(4): 191-200. Doi: 10.1007/s12254-016-0297-x
Web of Science FullText FullText_MUG

 

** Prochazka, KT; Melchardt, T; Posch, F; Schlick, K; Deutsch, A; Beham-Schmid, C; Weiss, L; Gary, T; Neureiter, D; Klieser, E; Greil, R; Neumeister, P; Egle, A; Pichler, M NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.
Br J Cancer. 2016; 115(10):1264-1272 Doi: 10.1038/bjc.2016.325 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Rezania, S; Kammerer, S; Li, C; Steinecker-Frohnwieser, B; Gorischek, A; DeVaney, TT; Verheyen, S; Passegger, CA; Tabrizi-Wizsy, NG; Hackl, H; Platzer, D; Zarnani, AH; Malle, E; Jahn, SW; Bauernhofer, T; Schreibmayer, W Overexpression of KCNJ3 gene splice variants affects vital parameters of the malignant breast cancer cell line MCF-7 in an opposing manner.
BMC Cancer. 2016; 16(1):628-628 Doi: 10.1186/s12885-016-2664-8 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Rief, P; Pichler, M; Raggam, R; Hafner, F; Gerger, A; Eller, P; Brodmann, M; Gary, T The AST/ALT (De-Ritis) ratio: A novel marker for critical limb ischemia in peripheral arterial occlusive disease patients.
Medicine (Baltimore). 2016; 95(24):e3843-e3843 Doi: 10.1097/MD.0000000000003843 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Schnedl, WJ; Kalmar, P; Wallner-Liebmann, SJ; Reiter, G; Mangge, H; Lipp, RW Anomaly of the inferior vena cava and lactose malabsorption
PHLEBOLOGIE. 2016; 45(1): 36-39. Doi: 10.12687/phleb2285-1-2016
Web of Science FullText FullText_MUG

 

** Seles, M; Hutterer, GC; Kiesslich, T; Pummer, K; Berindan-Neagoe, I; Perakis, S; Schwarzenbacher, D; Stotz, M; Gerger, A; Pichler, M Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma.
Int J Mol Sci. 2016; 17(4):573-573 Doi: 10.3390/ijms17040573 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Speicher, MR; Gerger, A; Hoefler, G Liquid biopsies. A multidisciplinary challenge for human geneticists, oncologists, and pathologists
MED GENET-BERLIN. 2016; 28(2): 245-250. Doi: 10.1007/s11825-016-0090-6 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Stotz, M; Liegl-Atzwanger, B; Posch, F; Mrsic, E; Thalhammer, M; Stojakovic, T; Bezan, A; Pichler, M; Gerger, A; Szkandera, J Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection.
PLoS One. 2016; 11(7):e0159448-e0159448 Doi: 10.1371/journal.pone.0159448 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Troppan, KT; Melchardt, T; Wenzl, K; Schlick, K; Deutsch, A; Bullock, MD; Reitz, D; Beham-Schmid, C; Weiss, L; Neureiter, D; Tränkenschuh, W; Greil, R; Neumeister, P; Egle, A; Pichler, M The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.
J Clin Pathol. 2016; 69(4):326-330 Doi: 10.1136/jclinpath-2015-203356
Web of Science PubMed FullText FullText_MUG

 

** Trummer, O; Langsenlehner, U; Krenn-Pilko, S; Pieber, TR; Obermayer-Pietsch, B; Gerger, A; Renner, W; Langsenlehner, T Vitamin D and prostate cancer prognosis: a Mendelian randomization study.
World J Urol. 2016; 34(4):607-611 Doi: 10.1007/s00345-015-1646-9 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Ulz, P; Belic, J; Graf, R; Auer, M; Lafer, I; Fischereder, K; Webersinke, G; Pummer, K; Augustin, H; Pichler, M; Hoefler, G; Bauernhofer, T; Geigl, JB; Heitzer, E; Speicher, MR Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer.
Nat Commun. 2016; 7(15):12008-12008 Doi: 10.1038/ncomms12008 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Ulz, P; Gerger, A; Belic, J; Heitzer, E Potentials, challenges and limitations of a molecular characterization of circulating tumor DNA for the management of cancer patients
LABORATORIUMSMEDIZIN. 2016; 40(5): 323-334. Doi: 10.1515/labmed-2016-0049 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Urbas, R; Mayr, C; Klieser, E; Fuereder, J; Bach, D; Stättner, S; Primavesi, F; Jaeger, T; Stanzer, S; Ress, AL; Löffelberger, M; Wagner, A; Berr, F; Ritter, M; Pichler, M; Neureiter, D; Kiesslich, T Relevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer Patients.
Int J Mol Sci. 2016; 17(12): Doi: 10.3390/ijms17122053 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Wibmer, C; Amrein, K; Fahrleitner-Pammer, A; Gilg, MM; Berghold, A; Hutterer, GC; Maurer-Ertl, W; Gerger, A; Leithner, A; Pichler, M; Szkandera, J Serum sclerostin levels in renal cell carcinoma patients with bone metastases.
Sci Rep. 2016; 6(4):33551-33551 Doi: 10.1038/srep33551 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Zebisch, A; Hatzl, S; Pichler, M; Wölfler, A; Sill, H Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs.
Int J Mol Sci. 2016; 17(12): Doi: 10.3390/ijms17122080 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Fabian, E; Haas, B; Kump, P; Lipp, R; Kornprat, P; Lutfi, A; Talakic, E; Fuchsjäger, M; Spindelboeck, W; Lackner, C; Zollner, G; Krejs, GJ Clinical–Pathological Conference Series from the Medical University of Graz, Case No 154: 32–year–old computer software engineer with nodular mass in the liver
Wiener Klinische Wochenschrift -Education. 2016; (- Case Report)
FullText

 

Gerger, A; Bauernhofer, T Zirkulierende Tumor-DNA - ready for prime time in colorectal cancer?
Jatros Haematologie und Onkologie. 2016; 1(16): 67-68.

 

Suppan, C; Balic, M Precision Medicine: Liquid Biopsy - interdisziplinär betrachtet.
Universum Innere Medizin. 2016; (04): 56-58.

 

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

** Belic, J; Heitzer, E; Ulz, P; Auer, M; Fischereder, K; Bauernhofer, T; Geigl, JB; Speicher, MR Analysis of ctDNA using the mFastSeqS and plasma-Seq methods for screening and therapy monitoring in prostate cancer patients
CLIN CANCER RES. 2016; 22: -Meeting of the American-Association-for-Cancer-Research (AACR) Precision Medicine Series - Integrating Clinical Genomics and Cancer Therapy; JUN 13-16, 2015; Salt Lake, UT. Doi: 10.1158/1557-3265.PMSCLINGEN15-PR05 [Oral Communication]
Web of Science FullText FullText_MUG

 

** Beyer-Westendorf, J; Kreutz, R; Posch, F; Ay, C The CHA2DS2-VASc score strongly correlates with glomerular filtration rate and predicts decline in renal function over time in patients with atrial fibrillation and chronic kidney disease
EUR HEART J. 2016; 37: 604-604.-Congress of the European-Society-of-Cardiology (ESC); AUG 27-31, 2016; Rome, ITALY. [Oral Communication]
Web of Science

 

** Cheli, S; Baider, L; Goldzweig, G; Andritsch, E; Gany, F Mediterrean Bridges and Drifts: The European Migrant Crisis and the Role of Psycho-oncology
PSYCHO-ONCOLOGY. 2016; 25(SP. S3):90-91.Dublin,Ireland. [Oral Communication]
Web of Science

 

** Deutsch, AJA; Rinner, B; Pichler, M; Fechter, K; Greinix, HT; Wang, CG; Beham-Schmid, C; Neumeister, P; NR4A3 Suppresses Lymphomagenesis In Vitro and In Vivo by Induction of Similar Patterns of Pro-Apoptotic Genes like NR4A1.
BLOOD. BLOOD128: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), San Diego, CA, DEC 03-06, 2016) Doi: 10.1182/blood.V128.22.2728.2728
Web of Science FullText FullText_MUG

 

** Gantenbein, N;Smolle, E;Thalhammer, M;Kornprat, P;Lackner, C;Spindelboeck, W;Kump, P;Lipp, R;Haybaeck, J Are eIFs Ingredients for Neuroendocrine Tumorigenesis?
NEUROENDOCRINOLOGY. 2016; 103: 2-3.-13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease; MAR 09-11, 2016; Barcelona, SPAIN. [Poster]
Web of Science

 

** Gnant, M; Pfeiler, G; Dubsky, PC; Hubalek, M; Greil, R; Jakesz, R; Wette, V; Balic, M; Haslbauer, F; Melbinger-Zeinitzer, E; Bjelic-Radisic, V; Artner-Matuschek, S; Fitzal, F; Marth, C; Sevelda, P; Mlineritsch, B; Steger, GG; Manfreda, D; Exner, R; Egle, D; Bergh, J; Kainberger, F; Talbot, S; Warner, D; Fesl, C; Singer, CF The impact of adjuvant denosumab on disease-free survival: Results from 3,425 postmenopausal patients of the ABCSG-18 trial
CANCER RES. 2016; 76: -38th Annual CTRC-AACR San Antonio Breast Cancer Symposium; DEC 08-12, 2015; San Antonio, TX. Doi: 10.1158/1538-7445.SABCS15-S2-02 [Keynote lecture]
Web of Science FullText FullText_MUG

 

** Hammer, P; Lipp, R; Thalhammer, M; Mischinger, HJ; Kornprat, P; Puntschart, A; Uranues, S; Haybaeck, J; Krejs, G; Kump, P Impact of Early Surgery on Prognosis in Advanced Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NET)
NEUROENDOCRINOLOGY. 2016; 103: 98-98.-13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease; MAR 09-11, 2016; Barcelona, SPAIN. [Poster]
Web of Science

 

** Holzer, S; Hochmair, M; Filipits, M; Mohn-Staudner, A; Errhalt, P; Absenger, G; Bundalo, T; Arns, BM; Setinek, U; Mikes, R; Kolb, R; Schumacher, M; Zochbauer-Muller, S; Patocka, K; Haslbauer, F; Rudzki, J; Burghuber, OC EGFR T790M resistance mutation in NSCLC: Real-life data of Austrian patients treated with osimertinib
WIEN KLIN WOCHENSCHR. 2016; 128(19-20):769-770. [Poster]
Web of Science

 

** Jahn-Kuch, D When is it time to discontinue cancer treatment?
ONCOL RES TREAT. 2016; 39: 2-2. [Oral Communication]
Web of Science

 

** Merola, E; Pavel, ME; Panzuto, F; Capurso, G; Cicchese, N; Rinke, A; Gress, TM; Iannicelli, E; Prosperi, D; Pizzichini, P; Kump, P; Lipp, R; Partelli, S; Falconi, M; Wiedenmann, B; Delle Fave, G Functional imaging tests and CT scan: Detection of new metastases and clinical usefulness in digestive neuroendocrine neoplasms follow-up.
J CLIN ONCOL. 2016; 34(4):-Gastrointestinal Cancers Symposium; JAN 21-23, 2016; San Francisco, CA. Doi: 10.1200/jco.2016.34.4_suppl.219 [Poster]
Web of Science FullText FullText_MUG

 

** Riedl, J; Posch, F; Stotz, M; Bezan, A; Winder, T; Schaberl-Moser, R; Pichler, M; Stoeger, H; Gerger, A Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK. Doi: 10.1093/annonc/mdw370.107 [Poster]
Web of Science FullText FullText_MUG

 

** Rinnerthaler, G; Gampenrieder, SP; Fridrik, M; Petzer, A; Hubalek, M; Petru, E; Jager, T; Andel, J; Balic, M; Ulmer, H; Mlineritsch, B; Greil, R Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Stage 1 results of a phase II trial (AGMT MBC-6)
CANCER RES. 2016; 76: -38th Annual CTRC-AACR San Antonio Breast Cancer Symposium; DEC 08-12, 2015; San Antonio, TX. Doi: 10.1158/1538-7445.SABCS15-P1-13-10 [Poster]
Web of Science FullText FullText_MUG

 

** Rinnerthaler, G; Gampenrieder, SP; Voskova, D; Petzer, A; Hubalek, M; Petru, E; Hartmann, B; Andel, J; Balic, M; Melchardt, T; Mlineritsch, B; Greil, R Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Updated safety results of a phase II trial (AGMT MBC-6)
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK. Doi: 10.1093/annonc/mdw365.18 [Poster]
Web of Science FullText FullText_MUG

 

** Scheithauer, W; Prager, G; Greil, R; Mlineritsch, B; Schaberl-Moser, R; Gerger, A; Langle, F; Viragos-Toth, I; Andel, J; Pichler, A; Pecherstorfer, M; Kretschmer, A; Seebacher, A; Jagdt, B; Eisterer, W; Krippl, P Secondary resectability rates observed in a multicenter randomized phase II study of modified capecitabine/ irinotecan (mXELIRI) plus bevacizumab (bev) followed by capecitabine/oxaliplatin (XELOX) plus bev or the reverse sequence in patients with metastatic colorectal cancer (mCRC)
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK. Doi: 10.1093/annonc/mdw370.41 [Poster]
Web of Science FullText FullText_MUG

 

** Schneider, C; Wallner, M; Abdellatif, M; von Lewinski, D; Pichler, M; Sedej, S; Rainer, P The anti-cancer tyrosine kinase inhibitor sorafenib reduces cardiac contractile force by reducing cardiomyocyte calcium transient amplitude
WIEN KLIN WOCHENSCHR. 2016; 128: S309-S310. [Poster]
Web of Science

 

** Silina, K; Petrausch, U; Posch, F; Leibl, S; Mundlein, A; Moch, H; Siebenhuner, A; Stupp, R; Riedl, J; Pestalozzi, BC; Schraml, P; Gerger, A; Winder, T Comprehensive molecular and immunological analysis to assess the tumor immune contexture in stage II and III colorectal cancer
ANN ONCOL. 2016; 27: Doi: 10.1093/annonc/mdw393.12
Web of Science FullText FullText_MUG

 

** Singer, CF; Filipits, M; Jahn, S; Abete, L; Jakesz, R; Greil, R; Bauernhofer, T; Kwasny, W; Seifert, M; Fitzal, F; Schmitt, M; Moinfar, F; Gnant, M Stromel co-expression of urokinase-type plasminogen activator (uPA) and plasminogen activator Inhibitor (PAI-1) protein by IHC predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer
CANCER RES. 2016; 76: -38th Annual CTRC-AACR San Antonio Breast Cancer Symposium; DEC 08-12, 2015; San Antonio, TX. Doi: 10.1158/1538-7445.SABCS15-P2-08-21 [Poster]
Web of Science FullText FullText_MUG

 

** Smolle, MA; Flick, H; Pichler, M; Olschewski, H; Lindenmann, J; Gerger, A Is it safe to use NSAIDs for pain control during chemical pleurodesis for malignant pleural effusion?
WIEN KLIN WOCHENSCHR. .. 2016; 128(19-20):772-773. [Poster]
Web of Science

 

** Winder, T; Posch, F; Asamer, E; Stotz, M; Siebenhuner, A; Schlick, K; Magnes, T; Samaras, P; Szkandera, J; Clavien, PA; Neureiter, D; Greil, R; Pestalozzi, BC; Stoeger, H; Gerger, A; Egle, A; Pichler, M An elevated fibrinogen/CRP ratio predicts a remarkable survival advantage in patients with metastatic pancreatic cancer
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK. Doi: 10.1093/annonc/mdw371.77 [Poster]
Web of Science FullText FullText_MUG

 

** Woitas, R; Scharnagl, H; Kleber, ME; Delgado, GE; Grammer, TB; Pichler, M; Kramer, BK; Marz, W; Stojakovic, T IMPACT OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN AND NEUTROPHIL COUNTS IN THE LUDWIGSHAFEN RISK AND CARDIOVASCULART HEALTH STUDY
ATHEROSCLEROSIS. 2016; 252: E67-E67.-Congress of the European-Atherosclerosis-Society (EAS); MAY 29-JUN 01, 2016; Innsbruck, AUSTRIA. Doi: 10.1016/j.atherosclerosis.2016.07.455 [Poster]
Web of Science FullText FullText_MUG

 

** Zollner-Schwetz, I; Zechner, E; Ullrich, E; Pux, C; Pichler, G; Schippinger, W; Krause, R; Leitner, E Colonization with multidrug-resistant Gram-negative bacteria in long time care facilities: prevalence and risk factors
WIEN KLIN WOCHENSCHR. 2016; 128: S387-S388. [Poster]
Web of Science

 

** Zweiker, D; Rosch, K; Schumacher, M; Stepan, V; Krippl, P; Bauer, N; Heine, M; Reicht, G; Zweiker, G; Watzinger, N Benefit and Risk Assessment for the Initiation of oral Anticoagulation in non-valvular Atrial Fibrillation: The Self-assessment by the Patient differs from the individual Risk Assessment by means of CHA2DS2-VASc and HASBLED Scores
WIEN KLIN WOCHENSCHR. 2016; 128: S391-S392. [Poster]
Web of Science

 

** Zweiker, D; Rosch, K; Schumacher, M; Stepan, V; Krippl, P; Heine, M; Reicht, G; Zweiker, G; Watzinger, N Benefit and Risk Assessment in Initiation of oral Anticoagulant in non valvularem Atrial Fibrillation: A Comparison between Self Assessment by the Patient and an individual Risk Assessment by CHA2DS2VASc and HAS-BLED Scores
WIEN KLIN WOCHENSCHR. 2016; 128: S299-S300. [Poster]
Web of Science

 

Balic, M ABCSG 18: Ergebnisse zum ontologischen Endpunkt
ABCSG Homepage. 2016; -25te Jahrestagung der ABCSG; 4.-5.11.2016; Saalfelden, Austria. [Keynote lecture]

 

Balic, M, Heitzer, E Klinische Anwendbarkeit von zirkulierender DNA
... 2016; -Combating Breast Cancer; 11.-12.11.; Duesseldorf, Germany. [Keynote lecture]

 

Balic M, Heitzer E Klinische Anwendbarkeit von zirkulierender DNA
ABCSG Homepage. 2016; -25te Jahrestagung der ABCSG; 4.-.5.11.2016; Saalfelden, Austria. [Keynote lecture]

 

Belic,J;Ulz,P; Graf, R; Auer, M; Fischereder, K; Hoefler, G; Bauernhofer, T, Geigl, JB; Heitzer, E; Speicher, MR Whole-genome sequencing of circulating tumor DNA reveals relevance of focal amplifications for the management of metastatic prostate cancer
Proceedings Book of the 24EACR. 2016; -EACR; JUL 9-12, 2016; Manchester, UK. [Poster]
FullText

 

Bezan, A; Posch, F; Ploner, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Gary, T; Samonigg, H; Gerger, A; Stotz, M; 23 Risk stratification for venous thromboembolism in patients with testicular germ cell tumours
European Urology Supplements. 2016; 15(3):E23--European Association of Urology (EAU) Annual Meeting; MAR 11-15, 2016; Munich, GERMANY. [Oral Communication]
FullText

 

De Santis, M; Bauernhofer,T; Stoiber, F; Höltl, L; Sommerhuber, A; Klocker, J; Meran, JG; Kilkovich,J; Colleseli, D; Dietrich, C; Pantel, K; Riethdorf, S; Circulating tumor cells (CTC) and Her-2 status on CTC and primary tumor in urothelial cancer (UC) patients refractory to platinum based chemotherapy.
Journal of Clinical Oncology. 2016; 34:(4s,):abstr.-4520.-ASCO Annual Meeting; JUN 3-7, 2016; Chicago, IL, USA. [Poster]

 

Deutsch, AJA; Rinner, B; Pichler, M; Fechter, K; Greinix, HT; Wang, C; Beham-Schmid, C; Neumeister, P NR4A3 Suppresses Lymphomagenesis In Vitro and In Vivo by Induction of Similar Patterns of Pro-Apoptotic Genes like NR4A1
Blood. 2016; -58th Anual Meeting of the American Society of Hematology; Dec 3-6, 2016; San Diego, CA, USA. [Poster]

 

Diana Bonilla, Kimberlyn Acklin, Kathryn Ruissard, Martin Pichler, Richard Jones, Anna Sergueeva, David Dwyer, Ryan Jewell, Veena Papanna, Shobana Vaidyanathan, Karen Ramirez, Karen Clise-Dwyer Development of a Multiplexing Imaging Flow Cytometry Assay for Apoptosis Evaluation
Cyto conference 2016. 2016; -31st Conference of the International Society for Advancement of Cytometry; JUN 11-15, 2016; Seattle, USA. [Poster]

 

Farkas,C; Zloklikovits,S; Andritsch,E The Essential Role of Existential Analysis in the Psycho-Social Care of Patients with Cancer in all Stages of the Disease.
Psycho -Oncology Journal of Psychological, Social and Behavioral Dimensions of Cancer. 2016; -IPOS International Psychooncology Society; OKT 17-21, 2016; Dublin, Irland. [Poster]

 

Gabriel Rinnerthaler, Simon Peter Gampenrieder, Daniela Voskova, Andreas L. Petzer, Michael Hubalek, Edgar Petru, Bernd Hartmann, Johannes Andel, Marija Balic, Hanno Ulmer, Thomas Melchardt, Brigitte Mlineritsch, Richard Greil Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Efficacy results of a phase II trial (AGMT MBC-6)
Journal of Clinical Oncology. 2016; -ASCO; 02.-06.06.2016; Chicago. [Poster]

 

Gantenbein, N; Smolle, E; Thalhammer, M; Kornprat, P; Lackner, C; Spindelboeck, W; Kump, P; Lipp, R; Haybaeck, J Are eIFs Ingredients for Neuroendocrine Tumorigenesis?
Abstract book page 23. 2016; -13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease ; MAR 9-11, 2016; Barcelona, SPAIN. [Poster]

 

Gilg, MM; Sunitsch, S; Leitner, L; Szkandera, J; Leithner, A; Liegl, B Tumour-associated mortality and prognostic factors in myxofibrosarcoma.
Abstracts of EMSOS 2016. 2016; -29th Annual Meeting of the European Musculo-Skeletal Oncology Society; MAY 25-27, 2016; La Baule, FRANCE. [Oral Communication]

 

Gilg, MM; Wibmer, C; Amrein, K; Fahrleitner-Pammer, A; Berghold, A; Ferstl-Rohrbacher, A; Maurer-Ertl, W; Gerger, A; Leithner, A; Pichler, M; Szkandera, J Serum sclerostin levels in renal cell carcinoma patients with bone metastases.
Abstracts of EMSOS 2016. 2016; -29th Annual Meeting of the European Musculo-Skeletal Oncology Society; MAY 25-27, 2016; La Baule, FRANCE. [Poster]

 

Heitzer, E; Perakis, S; Auer, M; Belic, J; Ulz, P; Lafer, I; Bauernhofer, T; Petru, E; Augustin, H; Geigl, JB; Speicher, MR. Clinical Utility of Circulating Tumor DNA Monitoring: A report of more than 400 plasma-Seqs
Medizinische Genetik. 2016; -GfH Tagung ; MAR 16-18, 2016; Lübeck, GERMANY. [Oral Communication]

 

Helmut H. Popper, Luka Brcic, Stefanie Stanzer, Gudrun Absenger, Joerg Lindenmann, Mohamed Al-Effah, Marija Balic Evaluation of immune tolerance mechanisms in pulmonary squamous cell and adenocarcinomas – how to interfere beyond PDL1 blockade
AACR Abstract book. 2016; -AACR, Annual Meeting ; April 2016; New Orleans, USA. [Poster]

 

Hochmair, M; Holzer, S; Filipits, M; Mohn-Staudner, A; Arns, M;, Errhalt, P; Absenger, G; Koller-Herzog, U; Setinek, U; Haslbauer, F; Korger, MA; Patocka, K; Kolb, R; Burghuber, O EGFR T790M resistance mutation in NSCLC: Real-life data of patients treated with osimertinib.
J Clin Oncol 34, 2016 (suppl; abstr e20572). 2016; -ASCO Annual Meeting ; Jun 3 -7, 2016 ; Chicago, USA.

 

HUI LING1, Masahisa Ohtsuka1, Martin Pichler2, Cristina Ivan1, Daisuke Matsushita1, George Calin1 The functional involvement of H19, a Long noncoding RNA, in human colorectal cancer
AACR Annual Meeting. 2016; -American Association for Cancer Research Annual Meeting; APR 16-20, 2016; New Orleans, USA. [Poster]

 

Martin Pichler1, Stefanie Cerk1, Verena Stiegelbauer1, Daniela Schwarzenbacher1, Hui Ling2 A novel long non-coding RNA, TSA-LINC2, regulates cellular growth and is associated with poor prognosis in breast cancer
AACR Annual Meeting. 2016; -American Association for Cancer Research Annual Meeting; APR 16-20, 2016; New Orleans, USA. [Poster]

 

Mohammed H. Rashed1, Pinar Kanlikilicer1, Cristian Rodriguez Aguayo1, Nashwa N. Kabil1, Martin Pichler1, Recep Bayraktar1, Emine Bayraktar1, Cristina Ivan1, Rahul Mitra1, George A. Calin1, Anil K. Sood1, Mohamed F. Abd-Ellah2, Gouda K. Helal2, Gabriel Lopez Berestein1 Ovarian cancer cells selectively release exosomes containing tumor suppressor miRNAs to maintain SRC-mediated oncogenic activities
AACR Annual Meeting. 2016; -American Association for Cancer Research Annual Meeting; APR 16-20, 2016; New Orleans, USA. [Poster]

 

Pinar Kanlikilicer, Mohammed Mohammed H. S. Rashed, Recep Bayraktar, Rahul Mitra, Cristina Ivan, Burcu Aslan, Xinna Zhang, Rodriguez-Aguayo Cristian, Emine Bayraktar, Martin Picher, Bulent Ozpolat, George A. Calin, Anil K. Sood, Gabriel Lopez-Berestein. Exosomal miR-6126 as a novel tumor suppressor in ovarian cancer
AACR Annual Meeting. 2016; -American Association for Cancer Research Annual Meeting; APR 16-20, 2016; New Orleans, USA. [Poster]

 

Posch, F; Leitner, L; Liegl-Atzwanger, B; Wink, A; Stotz, M; Bezan, A; Pichler, M; Gerger, A; Bergovec, M; Stoeger, H; Leithner, A; Szkandera, J Benefit of adjuvant radiotherapy for local control, distant metastasis, and survival outcomes in patients with localized soft tissue sarcoma: Comparative effectiveness analysis of an observational cohort study
Abstracts of CTOS 2016. 2016; -CTOS (Connective Tissue Oncology Society); Nov 9-12; Lisbon, PORTUGAL. [Oral Communication]

 

Posch, F; Leitner, L; Stotz, M; Liegl-Atzwanger, B; Bezan, A; Pichler, M; Friesenbichler, J; Gerger, A; Stoeger, H; Leithner, A; Szkandera, J Conditional survival of patients with soft tissue sarcoma (STS) after curative resection
Abstracts of CTOS 2016. 2016; -CTOS (Connective Tissue Oncology Society); NOV 9-12; Lisbon, PORTUGAL. [Poster]

 

Posch, F; Leitner, L; Stotz, M; Liegl-Atzwanger, B; Bezan, A; Pichler, M; Gerger, A; Bergovec, M; Stoeger, H; Leithner, A; Szkandera, J Local recurrence, distant metastasis, and death in patients with soft tissue sarcoma (STS) after curative resection: A multi-state model
Abstracts of CTOS 2016. 2016; -CTOS (Connective Tissue Oncology Society); NO 9-12; Lisbon, PORTUGAL. [Poster]

 

Recep Bayraktar, Martin Pichler Pichler, Cristina Ivan, George Calin, Bulent Ozpolat miR-603 acts as a tumor suppressor in triple-negative breast cancer and inhibits cell proliferation, invasiveness and tumorigenesis by targeting elongation factor 2-kinase (eEF2K)
AACR Annual Meeting. 2016; -American Association for Cancer Research Annual Meeting; APR 16-20, 2016; New Orleans, USA. [Poster]

 

Riedl, J; Posch, F; Stotz, M; Bezan, A; Winder, T; Schaberl-Moser, R; Pichler, M; Stoeger, H; Gerger, A Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance
Annals of Oncology. 2016; -ESMO congress; Oct 7-11; Copenhagen. [Poster]

 

Rinnerthaler G, Gampenrieder SP, Voskova D, Petzer A, Hubalek M, Petru E, Hartmann B, Andel J, Balic M, Melchardt T, Ulmer H, Mlineritsch B, Greil R Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Final PFS results of a phase II trial (AGMT MBC-6)
https://www.sabcs.org/Portals/SABCS2016/Documents/SABCS-2016-Abstracts.pdf?v=1. 2016; -San Antonio Breast Cancer Symposium; 06.-10.12.2016; San Antonio, TX, USA. [Poster]

 

Scheithauer, W; Prager, G; Greil, R; Mlineritsch, B; Schaberl-Moser, R; Gerger, A; Längle, F; Viragos-Toth, I; Andel, J; Pichler, A; Pecherstorfer, M; Kretschmer, A; Seebacher, A; Jagdt, B; Eisterer, W; Krippl, P Secondary resectability rates observed in a multicenter randomized phase II study of modified capecitabine/irinotecan (mXELIRI) plus bevacizumab (bev) followed by capecitabine/oxaliplatin (XELOX) plus bev or the reverse sequence in patients with metastatic colorectal cancer (mCRC)
Annals of Oncology. 2016; -ESMO congress; Oct 7-11; Copenhagen. [Poster]

 

Seles, M; Strini, KA; Pohlmann, K; Bezan, A; Pummer, K; Pichler, M; Zigeuner, R; Hutterer, GC Prognostische Bedeutung klinischer und histopathologischer Parameter hinsichtlich des Gesamtüberlebens beim Nierenzellkarzinom – Langzeitanalyse eines europäischen Single-Centers 1984-2013
GMS Ger Med Sci. 2016; doi: 10.3205/16urobay052, urn:nbn:de:0183-16urobay0523. 2016; -42. Gemeinsame Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie; JUN 2-4, 2016; Augsburg, Germany. [Oral Communication]
FullText

 

Silina, K; Petrausch, U; Posch, F; Leibl, S; Mündlein, A; Moch, A; Siebenhüner, A; Stupp, A; Riedl, J; Pestalozzi, BC; Schraml, P; Gerger, A; Winder, T Comprehensive molecular and immunological analysis to assess the tumor immune contexture in stage II and III colorectal cancer
Annals of Oncology. 2016; -ESMO congress; Oct 7-11; Copenhagen. [Poster]

 

Singer CF, Pfeiler G, Hubalek M, Bartsch R, Stoeger H, Pichler A, Petru E, Greil R, Rudas M, Tea M-KM, Wette V, Petzer AL, Sevelda P, Egle D, Dubsky PC, Balic M, Tinchon C, Bago-Horvath Z, Frantal S, Michael G Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomized, neoadjuvant phase-II study (ABCSG-34)
https://www.sabcs.org/Portals/SABCS2016/Documents/SABCS-2016-Abstracts.pdf?v=1. 2016; -San Antonio Breast Cancer Symposium; 06.-10.12.2016; San Antonio, TX, USA. [Poster]

 

Singer CF, Tan YY, Fitzal F, Steger GG, Egle D, Reiner A, Rudas M, Gruber C, Bartsch R, Fridrik M, Seifert M, Exner R, Balic M, Bago-Horvath Z, Filipits M, Gnant M Pathological complete response to neoadjuvant trastuzumab is dependent on HER2/CEP17 ratio in HER2-amplified early breast cancer
https://www.sabcs.org/Portals/SABCS2016/Documents/SABCS-2016-Abstracts.pdf?v=1. 2016; -San Antonio Breast Cancer Symposium; 06.-10.12.2016; San Antonio, TX, USA. [Poster]

 

Smolle, C; Reischies, F; Schratter, G; Reicher, A; Tiran, V; Dandachi, N; Parvizi, D; Kamolz, LP; Ghaffari-Tabrizi-Wiszy, N The effect of mesenchymal stem cells on breast cancer cell lines tested on the chick embryo chorioallantoic membrane: first results.
ALTEX Proceedings 5(1), 2016, LINZ 2016. 2016; 5(1):-17th EUSAAT (European Society for Alternatives to Animal Testing) Conference; AUG 24-27, 2016; Linz, AUSTRIA. [Poster]

 

Smolle, MA; Flick, H; Pichler, M; Olschewski, H; Lindenmann, J; Gerger, A LATE-BREAKING ABSTRACT: Impact of NSAIDs on success of chemical pleurodesis in malignant pleural effusion.
European Respiratory Journal 2016 48: PA3399. 2016; 48: -ERS International Congress ; SEP 3-7, 2016; London, UNITED KINGDOM. [Poster]
FullText

 

Smolle, MA; Goldenitsch, E; Machacek, F; Bezan, A; Pichler, M; Gerger, A; Bergovec, M; Stoeger, H; Leithner, A; Szkandera, J THERAPY AND OUTCOME OF PATIENTS FOLLOWING UNPLANNED EXCISIONS IN SOFT TISSUE SARCOMA: A MULTI- CENTRE EXPERIENCE.
Abstracts of CTOS 2016; P2-P185. 2016; -CTOS 2016; NOV 9-12, 2016; Lisbon, PORTUGAL. [Poster]

 

Smolle, MA; Pichler, M; Flick, H; Olschewski, H; Lindenmann, J; Samonigg, H; Gerger, A. Einfluss von nicht-steroidalen Antirheumatica (NSARs) sowie Laborparametern auf den Erfolg einer chemischen Pleurodese bei malignen Pleuraergüssen.
European Surgery, Supplement 1 Abstracts 57th Annual Meeting of the Austrian Society of Surgery. 2016; 48(1):46-46.-57. Österreichischer Chirurgenkongress; MAY 25- 27, 2016; Salzburg, AUSTRIA. [Oral Communication]

 

Smolle, MA; Szkandera, J; Leithner, A UNPLANNED EXCISIONS IN SOFT TISSUE SARCOMA: INFLUENCE ON THERAPY AND PATIENTS’ PROGNOSIS.
Book of Abstracts; 18. 2016; -11th CEOC; JUN 9-10, 2016; Prag, CZECH REPUBLIC. [Oral Communication]

 

Smolle, MA; Szkandera, J; Leithner, A Evaluating the influence of unplanned excisions in soft tissue sarcomas on therapy and patient’s survival.
Abstracts of EMSOS 2016. 2016; -29th Annual Meeting of the European Musculo-Skeletal Oncology Society; MAY 25-27, 2016; La Baule, FRANCE. [Poster]

 

Szkandera, J; Posch, F; Stotz, M; Liegl-Atzwanger, B; Pichler, M; Gerger, A; Friesenbichler, J; Leithner, A Conditional survival of patients with soft tissue sarcoma (STS) after curative Resection.
Abstracts of EMSOS 2016. 2016; -29th Annual Meeting of the European Musculo-Skeletal Oncology Society; MAY 25-27, 2016; La Baule, FRANCE. [Oral Communication]

 

Szkandera, J; Posch, F; Stotz, M; Liegl-Atzwanger, B; Pichler, M; Gerger, A; Friesenbichler, J; Leithner, A Local recurrence, distant metastasis, and death in patients with soft tissue sarcoma (STS) after curative resection: A multi-state model.
Abstracts of EMSOS 2016. 2016; -29th Annual Meeting of the European Musculo-Skeletal Oncology Society; MAY 25-27, 2016; La Baule, FRANCE. [Oral Communication]

 

Thomas Winder, Michael Stotz, Alexander Rheinhard Siebenhuener, Konstantin Schlick, Teresa Magnes, Panagiotis Samaras, Joanna Szkandera, Pierre-Alain Clavien, Daniel Neureiter, Richard Greil, Bernhard C. Pestalozzi, Armin Gerger, Alexander Egle, Martin Pichler The fibrinogen/CRP ratio as a novel prognostic parameter for pancreatic cancer patients
ASCO 2016. 2016; -ASCO; JUN 3-7, 2016; Chicago, USA. [Poster]

 

Vosberg, S; Hartmann, L; Metzeler, KH; Schumacher, D; Pastore, F; Bräundl, K; Zellmeier, E; Ksienzyk, B; Konstandin, NP; Schneider, S; Graf, A; Krebs, S; Blum, H; Neumann, M; Baldus, CD; Bohlander, SK; Wolf, S; Hiddemann, W; Spiekermann, K; Greif, PA Evolutionary Patterns of Cytogenetically Normal Acute Myeloid Leukemia Correlate with Time to Relapse.
Blood (2016) . 2016; -58th Annual Meeting of the American Society of Hematology; DEC 3-6, 2016; San Diego, USA. [Oral Communication]
FullText

 

ZLOKLIKOVITS, S; FARKAS, C; ANDRITSCH, E Psycho-Oncology Special Issue: Abstracts of the 2016 World Congress of Psycho-oncology, 17 – 21 October 2016, Dublin, Ireland Volume 25, Issue S3, October 2016, Pages 3–195 Fear of Cancer Recurrence and Sense of Coherence in an Austrian Sample of Breast Cancer Survivors.
Psycho-Oncology, 2016. 2016; -World Congress of Psychooncology; OCT 17-21, 2016; Dublin , Irland. [Poster]

 

Hochschulschriften ( Diplomarbeit, Dissertation, Habilitationsschrift )

Benezeder, T Multigene Methylation Analysis of Circulating Tumor Cells in Patients with Metastatic Breast Cancer.
[ Diplomarbeit/Master Thesis (UNI) ] University of Graz; 2016.

 

Originalbeiträge in Sammelwerk (Buch)

Ress, AL; Perakis, S; Pichler, M microRNAs and Colorectal Cancer
In: Santulli, G editors(s). microRNA:Cancer From Molecular Biology to Clinical Practise. (889): Springer; p. 89 - 104. 2016(ISBN: 978-3-319-23730-5)

 

Tiran, V; Balic, M; Dandachi, N CTC Analysis: FISH, ISH, Array-CGH, and Other Molecular Assays.
In: Cote, RJ; Datar, RH editors(s). Circulating Tumor Cells. Advances in Basic Science and Clinical Applications.. New York: Springer; p. 185-200. 2016(ISBN: 978-1-4939-3361-7)

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum